QT
ABMD

Quantamental Technologies’s Abiomed Inc ABMD Stock Holding History

Quantamental Technologies’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,097
Closed -$761K – 711
2022
Q3 		$761K Buy
+3,097
New +$836K 0.3% 105
2021
Q4 		– Sell
-2,801
Closed -$912K – 523
2021
Q3 		$912K Buy
+2,801
New +$949K 0.61% 42
2020
Q1 		– Sell
-2,048
Closed -$349K – 433
2019
Q4 		$349K Buy
2,048
+672
+49% +$125K 0.18% 209
2019
Q3 		$245K Buy
+1,376
New +$297K 0.08% 425
2019
Q2 		– Sell
-2,366
Closed -$676K – 1910
2019
Q1 		$676K Buy
+2,366
New +$786K 0.31% 48

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Quantamental Technologies's ABMD Position: Q4 2022 in Review

Quantamental Technologies sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,097 shares — an estimated $761K sold.

Quantamental Technologies first reported a position in ABMD in Q1 2019 and held it in 5 quarters. The position peaked at $912K in Q3 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Quantamental Technologies reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Quantamental Technologies sold 3,097 Abiomed Inc shares in Q4 2022, an estimated $761K.
  • Quantamental Technologies first reported a position in Abiomed Inc in Q1 2019 and held it in 5 quarters.
  • Quantamental Technologies's Abiomed Inc position peaked at $912K in Q3 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Quantamental Technologies's 13F filing for Q4 2022, filed 14 Feb 2023.